The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Aliskiren (trade names Tekturna and Rasilez) is the first in a class of drugs called direct renin inhibitors. It is used for essential (primary) hypertension.
The global Aliskiren market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Aliskiren is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Aliskiren is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Aliskiren in Hospital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Aliskiren include Noden Pharma. etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Aliskiren, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Aliskiren.
Report Scope
The Aliskiren market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Aliskiren market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Aliskiren companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Noden Pharma
Segment by Type
150 mg Tablet
300 mg Tablet
Segment by Application
Hospital
Drug store
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Aliskiren companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Aliskiren (trade names Tekturna and Rasilez) is the first in a class of drugs called direct renin inhibitors. It is used for essential (primary) hypertension.
The global Aliskiren market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Aliskiren is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Aliskiren is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Aliskiren in Hospital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Aliskiren include Noden Pharma. etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Aliskiren, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Aliskiren.
Report Scope
The Aliskiren market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Aliskiren market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Aliskiren companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Noden Pharma
Segment by Type
150 mg Tablet
300 mg Tablet
Segment by Application
Hospital
Drug store
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Aliskiren companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Aliskiren Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 150 mg Tablet
1.2.3 300 mg Tablet
1.3 Market by Application
1.3.1 Global Aliskiren Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Drug store
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Aliskiren Market Perspective (2019-2030)
2.2 Aliskiren Growth Trends by Region
2.2.1 Global Aliskiren Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Aliskiren Historic Market Size by Region (2019-2024)
2.2.3 Aliskiren Forecasted Market Size by Region (2025-2030)
2.3 Aliskiren Market Dynamics
2.3.1 Aliskiren Industry Trends
2.3.2 Aliskiren Market Drivers
2.3.3 Aliskiren Market Challenges
2.3.4 Aliskiren Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Aliskiren Players by Revenue
3.1.1 Global Top Aliskiren Players by Revenue (2019-2024)
3.1.2 Global Aliskiren Revenue Market Share by Players (2019-2024)
3.2 Global Aliskiren Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Aliskiren Revenue
3.4 Global Aliskiren Market Concentration Ratio
3.4.1 Global Aliskiren Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Aliskiren Revenue in 2023
3.5 Aliskiren Key Players Head office and Area Served
3.6 Key Players Aliskiren Product Solution and Service
3.7 Date of Enter into Aliskiren Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Aliskiren Breakdown Data by Type
4.1 Global Aliskiren Historic Market Size by Type (2019-2024)
4.2 Global Aliskiren Forecasted Market Size by Type (2025-2030)
5 Aliskiren Breakdown Data by Application
5.1 Global Aliskiren Historic Market Size by Application (2019-2024)
5.2 Global Aliskiren Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Aliskiren Market Size (2019-2030)
6.2 North America Aliskiren Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Aliskiren Market Size by Country (2019-2024)
6.4 North America Aliskiren Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Aliskiren Market Size (2019-2030)
7.2 Europe Aliskiren Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Aliskiren Market Size by Country (2019-2024)
7.4 Europe Aliskiren Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Aliskiren Market Size (2019-2030)
8.2 Asia-Pacific Aliskiren Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Aliskiren Market Size by Region (2019-2024)
8.4 Asia-Pacific Aliskiren Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Aliskiren Market Size (2019-2030)
9.2 Latin America Aliskiren Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Aliskiren Market Size by Country (2019-2024)
9.4 Latin America Aliskiren Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Aliskiren Market Size (2019-2030)
10.2 Middle East & Africa Aliskiren Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Aliskiren Market Size by Country (2019-2024)
10.4 Middle East & Africa Aliskiren Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Noden Pharma
11.1.1 Noden Pharma Company Detail
11.1.2 Noden Pharma Business Overview
11.1.3 Noden Pharma Aliskiren Introduction
11.1.4 Noden Pharma Revenue in Aliskiren Business (2019-2024)
11.1.5 Noden Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Aliskiren Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of 150 mg Tablet
Table 3. Key Players of 300 mg Tablet
Table 4. Global Aliskiren Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Aliskiren Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Aliskiren Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Aliskiren Market Share by Region (2019-2024)
Table 8. Global Aliskiren Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Aliskiren Market Share by Region (2025-2030)
Table 10. Aliskiren Market Trends
Table 11. Aliskiren Market Drivers
Table 12. Aliskiren Market Challenges
Table 13. Aliskiren Market Restraints
Table 14. Global Aliskiren Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Aliskiren Market Share by Players (2019-2024)
Table 16. Global Top Aliskiren Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Aliskiren as of 2023)
Table 17. Ranking of Global Top Aliskiren Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Aliskiren Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Aliskiren Product Solution and Service
Table 21. Date of Enter into Aliskiren Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Aliskiren Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Aliskiren Revenue Market Share by Type (2019-2024)
Table 25. Global Aliskiren Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Aliskiren Revenue Market Share by Type (2025-2030)
Table 27. Global Aliskiren Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Aliskiren Revenue Market Share by Application (2019-2024)
Table 29. Global Aliskiren Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Aliskiren Revenue Market Share by Application (2025-2030)
Table 31. North America Aliskiren Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Aliskiren Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Aliskiren Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Aliskiren Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Aliskiren Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Aliskiren Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Aliskiren Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Aliskiren Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Aliskiren Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Aliskiren Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Aliskiren Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Aliskiren Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Aliskiren Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Aliskiren Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Aliskiren Market Size by Country (2025-2030) & (US$ Million)
Table 46. Noden Pharma Company Detail
Table 47. Noden Pharma Business Overview
Table 48. Noden Pharma Aliskiren Product
Table 49. Noden Pharma Revenue in Aliskiren Business (2019-2024) & (US$ Million)
Table 50. Noden Pharma Recent Development
Table 51. Research Programs/Design for This Report
Table 52. Key Data Information from Secondary Sources
Table 53. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Aliskiren Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Aliskiren Market Share by Type: 2023 VS 2030
Figure 3. 150 mg Tablet Features
Figure 4. 300 mg Tablet Features
Figure 5. Global Aliskiren Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Aliskiren Market Share by Application: 2023 VS 2030
Figure 7. Hospital Case Studies
Figure 8. Drug store Case Studies
Figure 9. Aliskiren Report Years Considered
Figure 10. Global Aliskiren Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 11. Global Aliskiren Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Aliskiren Market Share by Region: 2023 VS 2030
Figure 13. Global Aliskiren Market Share by Players in 2023
Figure 14. Global Top Aliskiren Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Aliskiren as of 2023)
Figure 15. The Top 10 and 5 Players Market Share by Aliskiren Revenue in 2023
Figure 16. North America Aliskiren Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 17. North America Aliskiren Market Share by Country (2019-2030)
Figure 18. United States Aliskiren Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. Canada Aliskiren Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Europe Aliskiren Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Aliskiren Market Share by Country (2019-2030)
Figure 22. Germany Aliskiren Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. France Aliskiren Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. U.K. Aliskiren Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Italy Aliskiren Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Russia Aliskiren Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Nordic Countries Aliskiren Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Asia-Pacific Aliskiren Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Aliskiren Market Share by Region (2019-2030)
Figure 30. China Aliskiren Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Japan Aliskiren Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. South Korea Aliskiren Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Southeast Asia Aliskiren Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. India Aliskiren Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Australia Aliskiren Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Latin America Aliskiren Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Aliskiren Market Share by Country (2019-2030)
Figure 38. Mexico Aliskiren Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Brazil Aliskiren Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Middle East & Africa Aliskiren Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Aliskiren Market Share by Country (2019-2030)
Figure 42. Turkey Aliskiren Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Saudi Arabia Aliskiren Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Noden Pharma Revenue Growth Rate in Aliskiren Business (2019-2024)
Figure 45. Bottom-up and Top-down Approaches for This Report
Figure 46. Data Triangulation
Figure 47. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
